Literature DB >> 9832193

Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression.

F Bellivier1, C Henry, A Szöke, F Schürhoff, M Nosten-Bertrand, J Feingold, J M Launay, M Leboyer, J L Laplanche.   

Abstract

To explore the involvement of serotonin transporter (5HTT) in mood disorder, we studied two polymorphisms of the 5HTT gene (a variable number of tandem repeats in the second intron (VNTR) and a 44 bp insertion/deletion in the 5HTT linked polymorphic region (5-HTTLPR)) in a sample of unipolar and bipolar patients and controls. Homozygosity for the short variant of the 5-HTTLPR was significantly more frequent in bipolar patients than in controls (chi2 = 4.68, d.f. = 1, P = 0.03) whereas there was no difference between bipolar patients and controls for allele distribution, suggesting a recessive effect. The interaction between the two markers suggests that the two polymorphisms probably have independent effects to determine the susceptibility to affective disorder. Further studies are required to identify the precise phenotype associated with 5HTT polymorphisms in depressed patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832193     DOI: 10.1016/s0304-3940(98)00677-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  20 in total

Review 1.  Recent progress in the search for genes for bipolar disorder.

Authors:  J R Kelsoe
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

2.  Serotonin transporter gene polymorphism (5-HTTLPR) influences trait anxiety by modulating the functional connectivity between the amygdala and insula in Han Chinese males.

Authors:  Lin Zhang; Ling Liu; Xueting Li; Yiying Song; Jia Liu
Journal:  Hum Brain Mapp       Date:  2015-04-02       Impact factor: 5.038

3.  Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population.

Authors:  Xenia Gonda; Konstantinos N Fountoulakis; Gabriella Juhasz; Zoltan Rihmer; Judit Lazary; Andras Laszik; Hagop S Akiskal; Gyorgy Bagdy
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

4.  Molecular epidemiology of major depressive disorder.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Environ Health Prev Med       Date:  2009-01-20       Impact factor: 3.674

5.  Allelic association analysis of the functional insertion/deletion polymorphism in the promoter region of the serotonin transporter gene in bipolar affective disorder.

Authors:  Ivanor Meira-Lima; Leandro Michelon; Quirino Cordeiro; Hyong Jin Cho; Homero Vallada
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo.

Authors:  A MacKenzie; J Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

7.  Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression.

Authors:  Leonardo Tozzi; Angela Carballedo; Friedrich Wetterling; Hazel McCarthy; Veronica O'Keane; Michael Gill; Derrek Morris; Ciara Fahey; James Meaney; Thomas Frodl
Journal:  Neuropsychopharmacology       Date:  2015-06-16       Impact factor: 7.853

8.  An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects.

Authors:  S J Kim; Y S Kim; H S Lee; S Y Kim; C-H Kim
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

9.  How possible is the development of an operational psychometric method to assess the presence of the 5-HTTLPR s allele? Equivocal preliminary findings.

Authors:  Xenia Gonda; Konstantinos N Fountoulakis; Zoltan Rihmer; Andras Laszik; Hagop S Akiskal; Gyorgy Bagdy
Journal:  Ann Gen Psychiatry       Date:  2010-05-07       Impact factor: 3.455

10.  Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics.

Authors:  Alexandra E Shields; Douglas E Levy; David Blumenthal; Douglas Currivan; Mary McGinn-Shapiro; Kevin B Weiss; Recai Yucel; Caryn Lerman
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.